These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3935494)

  • 1. Treatment of gonorrhoea with cefotiam: activity in vitro and clinical results of a 1-gram single-dose regimen.
    Korting HC; Neubert U
    Dermatologica; 1985; 171(4):264-8. PubMed ID: 3935494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Neisseria gonorrhoeae to ceftizoxime in vitro and in vivo.
    Korting HC; Neubert U
    Chemotherapy; 1984; 30(5):322-7. PubMed ID: 6092006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cefotetan in uncomplicated gonorrhea.
    Korting HC; Abeck D; Neubert U
    Dermatologica; 1986; 173(5):237-44. PubMed ID: 3100355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea.
    McCormack WM; Mogabgab WJ; Jones RB; Hook EW; Wendel GD; Handsfield HH
    Sex Transm Dis; 1993; 20(5):269-73. PubMed ID: 8235924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of cefotiam and ceftizoxime against Neisseria gonorrhoeae in an in vitro model simulating plasma and cantharidal blister fluid levels after the single intramuscular application of one gram.
    Korting HC; Niederauer H; Ollert M
    Chemotherapy; 1986; 32(3):260-9. PubMed ID: 3086050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of rosoxacin, fosfomycin, cefotiam, and spectinomycin on beta-lactamase producing Neisseria gonorrhoeae.
    Dickgiesser N; Kuntz P
    Br J Vener Dis; 1984 Jun; 60(3):154-6. PubMed ID: 6329404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and skin blister fluid levels of cefotiam and cefmenoxime after single intramuscular application of 1 g in gonorrhea.
    Korting HC
    Chemotherapy; 1984; 30(5):277-82. PubMed ID: 6092005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised comparative study of ceftriaxone and spectinomycin in gonorrhoea.
    Panikabutra K; Ariyarit C; Chitwarakorn A; Saensanoh C; Wongba C
    Genitourin Med; 1985 Apr; 61(2):106-8. PubMed ID: 3156805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftizoxime in the treatment of uncomplicated gonorrhoea.
    Spencer RC; Smith T; Talbot MD
    Br J Vener Dis; 1984 Apr; 60(2):90-1. PubMed ID: 6322910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Neisseria gonorrhoeae to cefotaxime: in vitro studies and treatment results.
    Neubert U; Korting HC; Ruckdeschel G
    Arch Dermatol Res; 1982; 274(3-4):321-6. PubMed ID: 6299208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized study of cefotaxime versus ceftriaxone for uncomplicated gonorrhea.
    Mogabgab WJ; Lutz FB
    South Med J; 1994 Apr; 87(4):461-4. PubMed ID: 8153771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ceftizoxime and penicillin for the treatment of uncomplicated gonorrhoea.
    Lutz B; Mogabgab WJ; Parks D; Pauling B; Beville R
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():229-35. PubMed ID: 6296012
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women.
    Collier AC; Judson FN; Murphy VL; Leach LA; Root CJ; Handsfield HH
    Am J Med; 1984 Oct; 77(4C):68-72. PubMed ID: 6093523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of gonorrhea: comparison of cefotaxime and penicillin.
    Simpson ML; Khan MY; Siddiqui Y; Gruninger RP; Wigren DI
    Antimicrob Agents Chemother; 1981 May; 19(5):798-800. PubMed ID: 6271049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of aztreonam in the treatment of uncomplicated gonorrhoea.
    Spencer RC; Talbot MD
    Curr Med Res Opin; 1985; 9(9):591-3. PubMed ID: 2932303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of ceftriaxone and spectinomycin for treatment of uncomplicated gonorrhoea in men.
    Handsfield HH; Murphy VL
    Lancet; 1983 Jul; 2(8341):67-70. PubMed ID: 6134959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in-vitro activity of selected new beta-lactam antimicrobials against Neisseria gonorrhoeae.
    Khan MY; Siddiqui Y; Gruninger RP
    Br J Vener Dis; 1982 Aug; 58(4):228-30. PubMed ID: 6286034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men.
    Handsfield HH; Murphy VL; Holmes KK
    Antimicrob Agents Chemother; 1981 Dec; 20(6):839-40. PubMed ID: 6275788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
    Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA
    J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin G.
    Korting HC; Behrendt H; Roth KH; Neubert U
    Chemotherapy; 1984; 30(6):366-72. PubMed ID: 6097409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.